OCC 0.65% 38.8¢ orthocell limited

FDA significance, page-8

  1. 1,381 Posts.
    lightbulb Created with Sketch. 227
    Six words stood out when reading your post. THE OPPORTUNITY WITH CELGRO IS ENORMOUS, over time Orthocell and its products will be the go to procedures, 89% recovery, bloody awesome and with the correct rehabilitation and time 100% will be achievable
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.